Solid Q2 Performance: Philips reported a 6% increase in order intake and a 1% rise in comparable sales for Q2 2025, attributed mainly to strengths in Personal Health. Adjusted EBITA margin expanded by 130 basis points to 12.4%, stemming from improved gross margins and productivity measures.

Increased Full-Year Guidance: The company affirmed its full-year comparable sales growth outlook of 1% to 3% and raised its adjusted EBITA margin guidance to between 11.3% and 11.8%. This improved outlook considers recent tariff developments and is supported by robust order momentum and a solid order book.

China Market Dynamics: The performance in China remains cautious; however, the completion of destocking in the Personal Health segment paired with early signs of consumer spending recovery could lead to a positive shift in the second half of 2025. The company expressed optimism about gradually improving demand in the coming years.